BDBM103814 US8551978, I-84::US8816088, I-84::US9394275, I-84::US9572802, Compound I-84::US9682957, I-84

SMILES: CC(Cc1cc(CC(=O)NCc2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12

InChI Key: InChIKey=ODRNIPYHRVQXEY-ISARHTMVSA-N

Data: 5 KI  2 EC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 103814   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Muscarinic acetylcholine receptor M3 (Homo sapiens (Human))	BDBM103814 (US8551978, I-84 | US8816088, I-84 | US9394275, I-8...) Show SMILES CC(Cc1cc(CC(=O)NCc2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r| Show InChI InChI=1S/C51H55FN6O7/c1-33(53-32-46(60)41-17-20-45(59)50-42(41)18-21-47(61)56-50)28-37-29-35(14-19-43(37)52)30-48(62)54-31-34-12-15-38(16-13-34)57(2)49(63)24-27-58-25-22-39(23-26-58)65-51(64)55-44-11-7-6-10-40(44)36-8-4-3-5-9-36/h3-21,29,33,39,46,53,59-60H,22-28,30-32H2,1-2H3,(H,54,62)(H,55,64)(H,56,61)/t33?,46-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Theravance, Inc. US Patent					Assay Description Radioligand binding assay using muscarinic receptors.				US Patent US8551978 (2013) BindingDB Entry DOI: 10.7270/Q2Q81BPC
					More data for this Ligand-Target Pair
Muscarinic acetylcholine receptor M3 (Homo sapiens (Human))	BDBM103814 (US8551978, I-84 | US8816088, I-84 | US9394275, I-8...) Show SMILES CC(Cc1cc(CC(=O)NCc2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r| Show InChI InChI=1S/C51H55FN6O7/c1-33(53-32-46(60)41-17-20-45(59)50-42(41)18-21-47(61)56-50)28-37-29-35(14-19-43(37)52)30-48(62)54-31-34-12-15-38(16-13-34)57(2)49(63)24-27-58-25-22-39(23-26-58)65-51(64)55-44-11-7-6-10-40(44)36-8-4-3-5-9-36/h3-21,29,33,39,46,53,59-60H,22-28,30-32H2,1-2H3,(H,54,62)(H,55,64)(H,56,61)/t33?,46-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Theravance Respiratory Company, LLC US Patent					Assay Description Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell me...				US Patent US8816088 (2014) BindingDB Entry DOI: 10.7270/Q2TQ6068
					More data for this Ligand-Target Pair
Muscarinic acetylcholine receptor M3 (Homo sapiens (Human))	BDBM103814 (US8551978, I-84 | US8816088, I-84 | US9394275, I-8...) Show SMILES CC(Cc1cc(CC(=O)NCc2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r| Show InChI InChI=1S/C51H55FN6O7/c1-33(53-32-46(60)41-17-20-45(59)50-42(41)18-21-47(61)56-50)28-37-29-35(14-19-43(37)52)30-48(62)54-31-34-12-15-38(16-13-34)57(2)49(63)24-27-58-25-22-39(23-26-58)65-51(64)55-44-11-7-6-10-40(44)36-8-4-3-5-9-36/h3-21,29,33,39,46,53,59-60H,22-28,30-32H2,1-2H3,(H,54,62)(H,55,64)(H,56,61)/t33?,46-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.100	-14.2	n/a	n/a	n/a	n/a	n/a	n/a	37
Theravance Respiratory Company, LLC US Patent					Assay Description Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentr...				US Patent US9394275 (2016) BindingDB Entry DOI: 10.7270/Q2NS0SS8
					More data for this Ligand-Target Pair
Muscarinic acetylcholine receptor M3 (Homo sapiens (Human))	BDBM103814 (US8551978, I-84 | US8816088, I-84 | US9394275, I-8...) Show SMILES CC(Cc1cc(CC(=O)NCc2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r| Show InChI InChI=1S/C51H55FN6O7/c1-33(53-32-46(60)41-17-20-45(59)50-42(41)18-21-47(61)56-50)28-37-29-35(14-19-43(37)52)30-48(62)54-31-34-12-15-38(16-13-34)57(2)49(63)24-27-58-25-22-39(23-26-58)65-51(64)55-44-11-7-6-10-40(44)36-8-4-3-5-9-36/h3-21,29,33,39,46,53,59-60H,22-28,30-32H2,1-2H3,(H,54,62)(H,55,64)(H,56,61)/t33?,46-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Theravance Respiratory Company LLC US Patent					Assay Description compounds were performed with [3H]NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a con...				US Patent US9572802 (2017) BindingDB Entry DOI: 10.7270/Q2VH5QWS
					More data for this Ligand-Target Pair
Muscarinic acetylcholine receptor M3 (Homo sapiens (Human))	BDBM103814 (US8551978, I-84 | US8816088, I-84 | US9394275, I-8...) Show SMILES CC(Cc1cc(CC(=O)NCc2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r| Show InChI InChI=1S/C51H55FN6O7/c1-33(53-32-46(60)41-17-20-45(59)50-42(41)18-21-47(61)56-50)28-37-29-35(14-19-43(37)52)30-48(62)54-31-34-12-15-38(16-13-34)57(2)49(63)24-27-58-25-22-39(23-26-58)65-51(64)55-44-11-7-6-10-40(44)36-8-4-3-5-9-36/h3-21,29,33,39,46,53,59-60H,22-28,30-32H2,1-2H3,(H,54,62)(H,55,64)(H,56,61)/t33?,46-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Theravance Respiratory Company, LLC US Patent					Assay Description Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...				US Patent US9682957 (2017) BindingDB Entry DOI: 10.7270/Q23776WR
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM103814 (US8551978, I-84 | US8816088, I-84 | US9394275, I-8...) Show SMILES CC(Cc1cc(CC(=O)NCc2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r| Show InChI InChI=1S/C51H55FN6O7/c1-33(53-32-46(60)41-17-20-45(59)50-42(41)18-21-47(61)56-50)28-37-29-35(14-19-43(37)52)30-48(62)54-31-34-12-15-38(16-13-34)57(2)49(63)24-27-58-25-22-39(23-26-58)65-51(64)55-44-11-7-6-10-40(44)36-8-4-3-5-9-36/h3-21,29,33,39,46,53,59-60H,22-28,30-32H2,1-2H3,(H,54,62)(H,55,64)(H,56,61)/t33?,46-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	n/a	n/a	1	n/a	n/a	n/a	25
Theravance Respiratory Company, LLC US Patent					Assay Description cAMP assays were performed in a radioimmunoassay format using the Flashplate Adenylyl Cyclase Activation Assay System with [125I]-cAMP (NEN SMP004, P...				US Patent US9682957 (2017) BindingDB Entry DOI: 10.7270/Q23776WR
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM103814 (US8551978, I-84 | US8816088, I-84 | US9394275, I-8...) Show SMILES CC(Cc1cc(CC(=O)NCc2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r| Show InChI InChI=1S/C51H55FN6O7/c1-33(53-32-46(60)41-17-20-45(59)50-42(41)18-21-47(61)56-50)28-37-29-35(14-19-43(37)52)30-48(62)54-31-34-12-15-38(16-13-34)57(2)49(63)24-27-58-25-22-39(23-26-58)65-51(64)55-44-11-7-6-10-40(44)36-8-4-3-5-9-36/h3-21,29,33,39,46,53,59-60H,22-28,30-32H2,1-2H3,(H,54,62)(H,55,64)(H,56,61)/t33?,46-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	n/a	n/a	1	n/a	n/a	n/a	37
Theravance Respiratory Company, LLC US Patent					Assay Description cAMP assays were performed in a radioimmunoassay format using the Flashplate Adenylyl Cyclase Activation Assay System with [125I]-cAMP (NEN SMP004, P...				US Patent US9394275 (2016) BindingDB Entry DOI: 10.7270/Q2NS0SS8
					More data for this Ligand-Target Pair